Key result
Levosimendan is a novel drug that effectively prevents myocardial dysfunction in sepsis through anti-inflammatory effects, improved myocardial ischaemia, and increased myocardial contractility.
Why the study?
The heart is highly vulnerable to sepsis, prompting a review of the characteristics of sepsis-induced cardiomyopathy and the mechanisms and clinical role of levosimendan.
Does levosimendan improve myocardial dysfunction in patients with sepsis-induced cardiomyopathy?
Does levosimendan improve myocardial dysfunction in patients with sepsis-induced cardiomyopathy?
Levosimendan shows promise as a therapeutic option for sepsis-induced cardiomyopathy due to its pleiotropic cardioprotective and inotropic effects.
May support levosimendan in sepsis cardiomyopathy; leaves open confirmation by randomized trials.
The heart is one of the organs most vulnerable to sepsis. This review describes the general characteristics of sepsis-induced cardiomyopathy and the main pathogenesis of myocardial dysfunction in sepsis. Levosimendan is a novel drug for treatment of sepsis-induced myocardial dysfunction. This review also elaborates on the pathogenesis of levosimendan, including the mechanisms of its anti-inflammatory effects, improvement of myocardial ischaemia, increased synthesis of nitric oxide, vascular endothelial cell protection, increased myocardial contractility, improved diastolic function, and inhibition of hypoxia-inducible factor-1α expression. Many clinical studies have proven that levosimendan effectively prevents myocardial dysfunction in sepsis. In addition to the widespread use of levosimendan in patients with heart failure, the role of levosimendan in the treatment of patients with sepsis-induced cardiomyopathy will be increasingly studied and applied in the future.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2019) conducted a review in sepsis-induced cardiomyopathy. Levosimendan was evaluated. Levosimendan is a novel drug that effectively prevents myocardial dysfunction in sepsis through anti-inflammatory effects, improved myocardial ischaemia, and increased myocardial contractility.